This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Intravitreal brolucizumab is superior to panretinal laser photocoagulation in preserving visual acuity for patients with proliferative diabetic retinopathy, clinical trial data show.

Changes in Choroidal Thickness Following Panretinal Photocoagulation: A Retrospective Study from Al Qassim, Saudi Arabia.

There is no increased risk of tractional retinal detachment (TRD) associated with anti-VEGF (vascular endothelial growth factor) intravitreal injection only, compared with laser-only therapy, nor with ...

No, diabetes-related retinopathy is not reversible. But you can slow down progression or stop it from getting worse through diabetes management, eye injections, laser treatment, and more. Diabetic ...

Why did a 38-year-old woman with neurofibromatosis type 1 (NF1) develop choroidal Yasunari nodules in both eyes? That's what Danish clinicians had to figure out when the patient presented for a ...

SAN ANTONIO -- Visual acuity in patients with diabetic macular edema (DME) improved significantly after an early switch to a dexamethasone implant following inadequate response to anti-VEGF therapy, a ...

The phase 3 CONDOR trial found brolucizumab superior to panretinal laser photocoagulation for proliferative diabetic retinopathy, offering better vision outcomes and disease regression. The anti-VEGF ...